228 related articles for article (PubMed ID: 9522537)
1. [Cholestatic liver diseases--diagnosis and therapy. 3: Therapy of primary biliary cirrhosis].
Leuschner U
Fortschr Med; 1998 Jan; 116(1-2):37-9. PubMed ID: 9522537
[No Abstract] [Full Text] [Related]
2. Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
Levy C; Peter JA; Nelson DR; Keach J; Petz J; Cabrera R; Clark V; Firpi RJ; Morelli G; Soldevila-Pico C; Lindor K
Aliment Pharmacol Ther; 2011 Jan; 33(2):235-42. PubMed ID: 21083674
[TBL] [Abstract][Full Text] [Related]
3. [Cholestasis: drug therapy].
Leuschner U
Praxis (Bern 1994); 1998 Nov; 87(46):1532-6. PubMed ID: 9857764
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of primary biliary cirrhosis. The effect of ursodeoxycholic acid is questioned now].
Broomé U
Lakartidningen; 2000 May; 97(21):2585-7. PubMed ID: 10881517
[No Abstract] [Full Text] [Related]
5. Are therapeutic doses of ursodeoxycholic acid in the cure of primary biliary cirrhosis inadequate? Some clinical considerations.
Caponi A; Lisotti A; Grenci C; Roda E
Minerva Gastroenterol Dietol; 2008 Dec; 54(4):331-4. PubMed ID: 19047973
[No Abstract] [Full Text] [Related]
6. Ursodeoxycholic acid: a second look. Primary biliary cirrhosis: dashed hopes.
Prescrire Int; 2002 Jun; 11(59):67-9. PubMed ID: 12068838
[TBL] [Abstract][Full Text] [Related]
7. [-Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy-].
Rudi J; Schönig T; Stremmel W
Z Gastroenterol; 1996 Mar; 34(3):188-91. PubMed ID: 8650973
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study.
Nakai S; Masaki T; Kurokohchi K; Deguchi A; Nishioka M
Am J Gastroenterol; 2000 Jan; 95(1):326-7. PubMed ID: 10638623
[No Abstract] [Full Text] [Related]
9. Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
Treiber G; Malfertheiner P
J Clin Gastroenterol; 2005 Oct; 39(9):837-8; author reply 838. PubMed ID: 16145353
[No Abstract] [Full Text] [Related]
10. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
11. Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid.
Kurihara T; Niimi A; Maeda A; Shigemoto M; Yamashita K
Am J Gastroenterol; 2000 Oct; 95(10):2990-2. PubMed ID: 11051391
[No Abstract] [Full Text] [Related]
12. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
14. Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia.
Willot S; Uhlen S; Michaud L; Briand G; Bonnevalle M; Sfeir R; Gottrand F
Pediatrics; 2008 Dec; 122(6):e1236-41. PubMed ID: 19029197
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results.
Kaplan MM; Cheng S; Price LL; Bonis PA
Hepatology; 2004 Apr; 39(4):915-23. PubMed ID: 15057894
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
Lindor K
N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
[No Abstract] [Full Text] [Related]
17. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Hay JE
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
[TBL] [Abstract][Full Text] [Related]
18. [Cholestatic liver diseases: diagnosis and therapy of primary biliary cirrhosis].
Thimme R; Opitz OG; Kreisel W
Dtsch Med Wochenschr; 2002 Sep; 127(36):1823-6. PubMed ID: 12215926
[No Abstract] [Full Text] [Related]
19. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
Levy C; Angulo P
Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
[No Abstract] [Full Text] [Related]
20. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]